Metraipolis › archive › dc_640f750cf53e

Metformin enhances alpelisib sensitivity in HER2+ breast cancer by suppressing cancer stemness and oncogenic signaling — Europe PMC PMID:41347072

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41347072
DOI
10.3389/fonc.2025.1631415
License (as archived)
solo-consultazione
Archived
2026-11-08T10:15:27.492Z
SHA-256 of the archived text
0ae8ddaaa7cfdd24e15d2f3397f80b01194f63e872a7349e07fb3dd775272142
Stable URL of this page
https://metraipolis.com/documento/dc_640f750cf53e

How to cite

Metformin enhances alpelisib sensitivity in HER2+ breast cancer by suppressing cancer stemness and oncogenic signaling — Europe PMC PMID:41347072 — Europe PMC (en), https://europepmc.org/article/MED/41347072 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_640f750cf53e (Metraipolis archive dc_640f750cf53e, sha256 0ae8ddaaa7cfdd24e15d2f3397f80b01194f63e872a7349e07fb3dd775272142)
BibTeX
@misc{dc640f750cf53e,
  title = {Metformin enhances alpelisib sensitivity in HER2+ breast cancer by suppressing cancer stemness and oncogenic signaling — Europe PMC PMID:41347072},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41347072},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_640f750cf53e; sha256 0ae8ddaaa7cfdd24e15d2f3397f80b01194f63e872a7349e07fb3dd775272142},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41347072. Agents can read the archived copy with the MCP tool read_document.